QGEN QGEN
Company Profile ↓Company Overview
QGEN (QGEN) is a publicly traded company listed on with a market capitalization of $8.68B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Maintains a net profit margin of 20.3%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $2.09B (+5.7% YoY); net profit $424.88M.
- Trailing 12 Months Year-on-year growth — revenue +5.7%, earnings +408.3%.
- 5-Year Trend Long-term compounding — revenue CAGR -0.8%, profit CAGR 0.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -0.81% |
| 1 Year: | 5.65% |
Compounded Profit Growth
| 5 Years: | 0.13% |
| 1 Year: | 408.28% |
Stock Price Performance
| 1 Year: | -15.76% |
| 6 Months: | -18.43% |
| 3 Months: | +24.50% |
| 1 Month: | +8.34% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)59.98 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 20.3%.
- Generates positive free cash flow.
CONS
- Revenue declined at -0.8% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 483.46M | 533.54M | 532.58M | 540.42M | 492.32M |
| Cost of Revenue | 174.78M | 199.25M | 201.32M | 215.15M | 182.72M |
| Gross Profit | 308.68M | 334.29M | 331.26M | 325.27M | 309.60M |
| Operating Expenses | 183.52M | 198.31M | 193.97M | 203.39M | 192.98M |
| Operating Income | 125.16M | 135.97M | 137.29M | 121.88M | 116.63M |
| EBITDA | 170.75M | 183.90M | 193.91M | 168.70M | 148.09M |
| Interest Expense | 7.29M | 7.61M | 8.22M | 10.14M | 11.05M |
| Pretax Income | 119.55M | 126.82M | 134.73M | 109.17M | 85.83M |
| Tax Provision | 28.79M | 30.57M | 4.68M | 1.34M | 17.79M |
| Net Income | 90.76M | 96.25M | 130.04M | 107.83M | 68.04M |
| Diluted EPS | 0.41 | 0.46 | 0.63 | 0.52 | 0.33 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 2.14B | 1.97B | 1.98B | 2.09B |
| Cost of Revenue | - | 756.96M | 731.62M | 1.01B | 790.50M |
| Gross Profit | - | 1.38B | 1.23B | 967.35M | 1.30B |
| Operating Expenses | - | 808.34M | 788.44M | 767.45M | 779.18M |
| Operating Income | - | 576.23M | 445.25M | 199.90M | 520.31M |
| EBITDA | - | 779.36M | 688.55M | 368.26M | 717.27M |
| Interest Expense | - | 58.36M | 53.41M | 43.84M | 33.26M |
| Pretax Income | - | 512.60M | 429.81M | 121.15M | 490.26M |
| Tax Provision | - | 89.39M | 88.51M | 37.56M | 65.39M |
| Net Income | - | 423.21M | 341.30M | 83.59M | 424.88M |
| Diluted EPS | - | 2.79 | 1.65 | 0.40 | 2.04 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 6.29B | 6.12B | 5.69B | 6.28B |
| Current Assets | - | 2.39B | 2.15B | 1.96B | 2.00B |
| Cash & Equivalents | - | 730.67M | 668.08M | 663.55M | 839.00M |
| Inventory | - | 357.96M | 398.38M | 279.26M | 301.89M |
| Receivables | - | 323.75M | 381.88M | 349.28M | 402.61M |
| Total Liabilities | - | 2.82B | 2.31B | 2.12B | 2.50B |
| Current Liabilities | - | 974.52M | 1.08B | 1.04B | 512.14M |
| Long Term Debt | - | 1.47B | 921.82M | 839.66M | 1.65B |
| Total Debt | - | 1.88B | 1.53B | 1.51B | 1.81B |
| Total Equity | - | 3.47B | 3.81B | 3.57B | 3.78B |
| Shares Outstanding | - | 206.80M | 206.80M | 206.80M | 206.80M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 715.26M | 459.45M | 673.55M | 654.33M |
| Investing Cash Flow | - | -726.76M | -87.66M | -249.23M | -305.28M |
| Financing Cash Flow | - | -125.80M | -433.83M | -422.90M | -178.98M |
| Capital Expenditure | - | -149.34M | -162.80M | -171.24M | -207.13M |
| Free Cash Flow | - | 565.93M | 296.65M | 502.31M | 447.20M |
| Net Change in Cash | - | -137.30M | -62.03M | 1.43M | 170.07M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 64.7% | 62.8% | 48.9% | 62.2% |
| Operating Margin % | - | 26.9% | 22.7% | 10.1% | 24.9% |
| Net Margin % | - | 19.8% | 17.4% | 4.2% | 20.3% |
| ROE % | - | 12.2% | 9.0% | 2.3% | 11.2% |
| ROCE % | - | 10.8% | 8.8% | 4.3% | 9.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for QGEN
Qiagen (QGEN) Stock Could Be A Cash Flow Bargain Yet Fair On Earnings - webull.com
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE9fNHAycEdOQnl0UUtka1Q4RXpXUjExaDFDNGo2a1VQN1VpSXdLWXY1UUpFellycm9LdnViWmZ1NDFBV0FBS3ZVQVU4WVVKd1FWYnk1VE1FS1c?oc=5" target="_blank">Qiagen (QGEN) Stock Could Be A Cash Flow Bargain…
Janus Henderson Group PLC Makes New Investment in Qiagen N.V. $QGEN - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPalNiejc4NHI3Y0ZGeC1HbUpRR3l4ZXVOejYwZ01IeHFnbVpXM1l6MTJ2SWNQTkF5T2hJd2k0REg3ODBnYktQNDdjMWhORGt5VUVWRjB2SE1pV0M3VVBqRGN2QTlydWJWX01lT2NNczgzUi0waUxKRVZwanFJLWJpNFVsZ1FZNGJ3ODVCcU…
QGEN Stock Slumps After-Hours On Guidance Cut Tied To Weak TB Test Demand - Stocktwits
<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxOUGo1STV1c1dnZ0dwX2NmOHI4X1NleDJlc2pSNTdyelU2OE5xc2Nrb0h5b25aLXZfdms5bE5vRVRJZk5JWG9fX2VGVUZwMkdKNktJelhRV0V6VDh1YVBxWlpiTkt4RG1EWHdWV2lEaTF2aUd2emtCNE5IaXVTWDI3azFMb2QxR2p5MlV2ek…
Qiagen (QGEN) Stock May Be 23% Below Fair Value Despite Takeover Interest - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPX2FxQmRxREtObGJiYWh0V0piVU1PZllYaU1JTnRMaXJqczFDazh0TTd4SnBxVW9hdnhtd0dNWHJFZ2xwZnlNMlkyZEZBQmtjeWNLSDhmTnY3QW9sMDV1eEZ1anBReUVMTnlUWVp0N1ZrMXBtS2F3MFpRREFuNUJUSUJtTjRlZTRuXzlkcE…
Behavioral Patterns of QGEN and Institutional Flows - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxPTno2SXYwT3ZXUlZzcVpoZzlTTGR6aTNGcUxrWW8xUjVSNWpKT0M5UmNoQ3ZvYzdZdWVvN1JXTEc4ck9BSjBWb3VQMkswRjFraE1zZU1YMi1ocXNvaXIxMEVUZ1VQbW42ZHRjOEtSNVRTZURTazV5YW14OWVDWVNwc2dLczBiVnlvX0pfQl…
When Stock Markets Become a Single Bet - WSJ
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxOREdjY3FFd1ZYT3VLUHoxR09VZXhSbHBBaDJ3UE1uUGVJSFVncHVCYXhxUTgtdWhyMC1veGU5ZmRuQ05jel8wY21GYm1idHhhcmFOY29TdURtcEZBSkU0RlN3OHFCenFtbHE3N1dZNGUwSE8xT2pxbXBGM0twWnJKM2FEUVRGcHpkY3c?oc…
QGEN — Frequently Asked Questions
What is the current share price of QGEN?
As of 2026-08-05 17:25 PDT, QGEN trades at $41.95 on NASDAQ/NYSE. Its 52-week range is $32.34 to $55.16.
What is the market capitalisation of QGEN?
QGEN has a market capitalisation of $8.68B on NASDAQ/NYSE.
What is the P/E ratio of QGEN?
QGEN trades at a trailing price-to-earnings (P/E) ratio of 20.54. Its price-to-book (P/B) ratio is 2.30.
What is the return on equity (ROE) of QGEN?
QGEN has a return on equity (ROE) of 11.25%. Its return on capital employed (ROCE) is 9.02%.
Is QGEN a good stock to buy?
This page provides a data-driven analysis of QGEN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.